{
  "schema_version": "0.4",
  "ir_kind": "core",
  "metadata": {
    "title": "Protocol",
    "source": {
      "type": "paper_pdf",
      "id": "s41596-023-00814-x.pdf"
    }
  },
  "resources": {
    "materials": [],
    "containers": [],
    "equipment": [],
    "samples": [],
    "data": []
  },
  "protocol": {
    "steps": [
      {
        "id": "s1",
        "op": "annotate",
        "params": {
          "note": "Check each iPSC line for pluripotency by standard differentiation protocol into ecto-, meso-, and endoderm germ layers using traditional markers."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s2",
        "op": "annotate",
        "params": {
          "note": "Ensure iPSC lines are free from contaminants."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s3",
        "op": "annotate",
        "params": {
          "note": "For genetic disease modeling, obtain patient-derived iPSCs from biobanks or reprogram patient materials; use CRISPR-Cas9 to introduce disease-causing mutations in isogenic iPSCs if needed."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s4",
        "op": "annotate",
        "params": {
          "note": "For live imaging, use transgenic iPSC lines with fluorescent reporters under tissue-specific promoters (e.g., retinal progenitors or eye field)."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s5",
        "op": "annotate",
        "params": {
          "note": "For cell lineage tracing, apply barcoding methods at the iPSC level before differentiation."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s6",
        "op": "annotate",
        "params": {
          "note": "Use iPSCs from at least two healthy donors of same gender, cell origin, and age group as control for patient iPSCs."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s7",
        "op": "annotate",
        "params": {
          "note": "For CRISPR-Cas9-engineered iPSCs, use the parental cell line as isogenic control."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s8",
        "op": "annotate",
        "params": {
          "note": "For ectopic expression of mutant transgene, use original cell line expressing wild-type gene as control."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s9",
        "op": "annotate",
        "params": {
          "note": "OVB organoids can be generated from five human iPSC lines; pigmented area formation varies significantly between lines."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s10",
        "op": "annotate",
        "params": {
          "note": "Somatic memory effect observed: CRX-iPSCs reprogrammed from Müller ganglion cells showed earlier RPE cell occurrence."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s11",
        "op": "annotate",
        "params": {
          "note": "Protocol can be modified to study forebrain development, axis formation, cyclopia, ganglionic eminence, optic stalk, or optic tract by adding media supplements (e.g., BDNF, GDNF, BrainPhys medium)."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s12",
        "op": "annotate",
        "params": {
          "note": "Set up at least three independent experiments (N = 3 batches); each batch starts from iPSC thawing and proceeds through differentiation."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s13",
        "op": "annotate",
        "params": {
          "note": "For each batch, analyze at least three individual organoids (n = 3) per timepoint, treatment, or condition."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s14",
        "op": "annotate",
        "params": {
          "note": "For four analysis methods (IF, western blot, ERGs, qRT-PCR), use n = 12 organoids per method (3 per method per batch)."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s15",
        "op": "annotate",
        "params": {
          "note": "Validation of successful differentiation is only possible after 30 days of culture."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s16",
        "op": "annotate",
        "params": {
          "note": "Culturing OVB organoids beyond 60 days leads to degradation and collapse."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s17",
        "op": "annotate",
        "params": {
          "note": "Unique expertise required for human iPSC cultivation and differentiation."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s18",
        "op": "annotate",
        "params": {
          "note": "Culturing optimization may be needed due to erratic behavior of iPSC donors."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s19",
        "op": "annotate",
        "params": {
          "note": "OVB organoids mature to Capowski stage 2–3; lack mature retinal cell types and retina-cortex connectivity."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s20",
        "op": "annotate",
        "params": {
          "note": "Quality check: pigmented areas visible by eye or magnifier."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s21",
        "op": "annotate",
        "params": {
          "note": "Generation of ~40 OVB organoids per batch is realistic; manual processing limits scalability."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s22",
        "op": "annotate",
        "params": {
          "note": "Due to dominant brain tissue, retinal/non-neuronal cell types are limited in bulk or scRNA-seq, requiring many organoids and reducing cost-effectiveness."
        },
        "inputs": [],
        "outputs": []
      }
    ],
    "start_step_id": "s1",
    "edges": [
      {
        "from": "s1",
        "to": "s2"
      },
      {
        "from": "s2",
        "to": "s3"
      },
      {
        "from": "s3",
        "to": "s4"
      },
      {
        "from": "s4",
        "to": "s5"
      },
      {
        "from": "s5",
        "to": "s6"
      },
      {
        "from": "s6",
        "to": "s7"
      },
      {
        "from": "s7",
        "to": "s8"
      },
      {
        "from": "s8",
        "to": "s9"
      },
      {
        "from": "s9",
        "to": "s10"
      },
      {
        "from": "s10",
        "to": "s11"
      },
      {
        "from": "s11",
        "to": "s12"
      },
      {
        "from": "s12",
        "to": "s13"
      },
      {
        "from": "s13",
        "to": "s14"
      },
      {
        "from": "s14",
        "to": "s15"
      },
      {
        "from": "s15",
        "to": "s16"
      },
      {
        "from": "s16",
        "to": "s17"
      },
      {
        "from": "s17",
        "to": "s18"
      },
      {
        "from": "s18",
        "to": "s19"
      },
      {
        "from": "s19",
        "to": "s20"
      },
      {
        "from": "s20",
        "to": "s21"
      },
      {
        "from": "s21",
        "to": "s22"
      }
    ],
    "detail_level": 0
  }
}